Bristol-Myers Squibb Co (BMY)
53.58
+0.33
(+0.62%)
USD |
NYSE |
Mar 28, 10:01
Bristol-Myers Squibb Research and Development Expense (TTM): 9.299B for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 9.299B |
September 30, 2023 | 9.331B |
June 30, 2023 | 9.507B |
March 31, 2023 | 9.57B |
December 31, 2022 | 9.509B |
September 30, 2022 | 9.517B |
June 30, 2022 | 10.08B |
March 31, 2022 | 10.24B |
December 31, 2021 | 10.20B |
September 30, 2021 | 11.43B |
June 30, 2021 | 10.95B |
March 31, 2021 | 10.99B |
December 31, 2020 | 11.14B |
September 30, 2020 | 9.49B |
June 30, 2020 | 8.369B |
March 31, 2020 | 7.172B |
December 31, 2019 | 6.148B |
September 30, 2019 | 5.418B |
June 30, 2019 | 5.32B |
March 31, 2019 | 6.43B |
December 31, 2018 | 6.332B |
September 30, 2018 | 6.89B |
June 30, 2018 | 7.171B |
March 31, 2018 | 6.415B |
December 31, 2017 | 6.468B |
Date | Value |
---|---|
September 30, 2017 | 6.015B |
June 30, 2017 | 5.592B |
March 31, 2017 | 5.179B |
December 31, 2016 | 5.012B |
September 30, 2016 | 5.456B |
June 30, 2016 | 5.45B |
March 31, 2016 | 6.04B |
December 31, 2015 | 5.92B |
September 30, 2015 | 5.193B |
June 30, 2015 | 5.044B |
March 31, 2015 | 4.604B |
December 31, 2014 | 4.534B |
September 30, 2014 | 4.302B |
June 30, 2014 | 4.212B |
March 31, 2014 | 3.747B |
December 31, 2013 | 3.731B |
September 30, 2013 | 3.856B |
June 30, 2013 | 3.914B |
March 31, 2013 | 3.925B |
December 31, 2012 | 3.904B |
September 30, 2012 | 3.83B |
June 30, 2012 | 3.852B |
March 31, 2012 | 3.813B |
December 31, 2011 | 3.839B |
September 30, 2011 | 3.841B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.32B
Minimum
Jun 2019
11.43B
Maximum
Sep 2021
9.005B
Average
9.508B
Median
Research and Development Expense (TTM) Benchmarks
Amgen Inc | 4.784B |
Gilead Sciences Inc | 5.719B |
Johnson & Johnson | 15.37B |
Karuna Therapeutics Inc (DELISTED) | 364.10M |
2seventy bio Inc | 230.76M |